Skip to main content

Daniel Farraye

ID:LEX-AR-40TKF6DS

/

Unclaimed

/

Organization: Goodwin Procter

Accord Biopharma Announces FDA Approval of IMULDOSA (ustekinumab-srlf)

Big Molecule Watch · October 24, 2024

FDA Seeks Input on Biosimilar Product Development Guidance

Big Molecule Watch · August 20, 2024

FDA Approves Moderna’s mRESVIA Vaccine

Big Molecule Watch · June 6, 2024

FDA Launches Support for Clinical Trials Advancing Rare Disease Therapeutics (START) Pilot Program

Big Molecule Watch · June 4, 2024

Alvotech Announces More Settlements and Expected Launch Dates Regarding Biosimilar to STELARA (ustekinumab), AVT04

Big Molecule Watch · February 23, 2024